Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-masked, Randomized Study to Compare the Efficacy and Safety of a New Artificial Tear Formulation (011516X) With Systane® Ultra Multidose for 90 Days in Participants With Dry Eye Disease

NCT04393441 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT04393441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04393441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-masked, Randomized Study to Compare the Efficacy and Safety of a New Artificial Tear Formulation (011516X) With Systane® Ultra Multidose for 90 Days in Participants With Dry Eye Disease
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
June 29, 2020
Completion date
June 15, 2021
Enrollment
400 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)